echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > The Synthetic Routes of 8-acetylquinoline

    The Synthetic Routes of 8-acetylquinoline

    • Last Update: 2023-05-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The synthesis of 8-acetylquinoline is an important process in the chemical industry, as this compound finds use in the production of various pharmaceuticals and other chemical products.
    There are several synthetic routes that can be used to produce 8-acetylquinoline, each with its own advantages and disadvantages.


    One of the most common synthetic routes involves the reaction of acetyl chloride with quinoline in the presence of a solvent such as acetonitrile or benzene.
    This reaction is exothermic and requires careful handling to avoid the formation of explosive products.
    The product is then isolated by precipitating it with sodium hydroxide and filtering off the solid.
    This method is relatively simple and readily available, making it a popular choice in the industry.


    Another synthetic route involves the reduction of 8-bromoquinoline using hydrogen in the presence of a catalyst such as palladium on barium oxide.
    The product is then converted to 8-acetylquinoline by reaction with acetyl chloride in the presence of a solvent such as acetone or ethanol.
    This method is more complex than the first route, but it does not require the handling of potentially hazardous acetyl chloride.


    A third synthetic route involves the reaction of quinoline with acetyl bromide in the presence of an acid catalyst such as sulfuric acid.
    The product is then isolated by filtration and purification.
    This method is similar to the first route, but it requires the use of a more hazardous reagent in the form of acetyl bromide.


    The choice of synthetic route depends on various factors, such as the desired yield, purity, and cost of the final product.
    In addition, the specific conditions of the reaction, such as the solvent, temperature, and catalyst used, can also affect the yield and purity of the product.


    Once synthesized, 8-acetylquinoline can be used in a variety of applications.
    For example, it is a key intermediate in the production of the antimalarial drug chloroquine, as well as in the synthesis of other pharmaceuticals and chemical products.
    Its unique structure and properties make it a valuable building block in organic chemistry, and its synthesis continues to be an important area of research in the field.


    In conclusion, the synthesis of 8-acetylquinoline is an important process in the chemical industry, with several synthetic routes available.
    The choice of route depends on various factors, such as the desired yield, purity, and cost of the final product.
    Once synthesized, 8-acetylquinoline can be used in a variety of applications, making it a valuable compound in the production of pharmaceuticals and other chemical products.



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.